Earnings Report: GVS S.p.A. Missed Revenue Estimates By 8.1%

Investors in GVS S.p.A. (BIT:GVS) had a good week, as its shares rose 3.0% to close at €4.33 following the release of its quarterly results. Revenues came in 8.1% below expectations, at €100m. Statutory earnings per share were relatively better off, with a per-share profit of €0.19 being roughly in line with analyst estimates. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from GVS' four analysts is for revenues of €456.6m in 2026. This would reflect a notable 8.2% increase on its revenue over the past 12 months. In the lead-up to this report, the analysts had been modelling revenues of €460.6m and earnings per share (EPS) of €0.24 in 2026. So we can see that while the consensus made no real change to its revenue estimates, it also no longer provides an earnings per share estimate. This suggests that revenues are what the market is focusing on after the latest results.

View our latest analysis for GVS

There's been no real change to the consensus price target of €5.98, with GVS seemingly executing in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on GVS, with the most bullish analyst valuing it at €7.50 and the most bearish at €5.30 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the GVS' past performance and to peers in the same industry. It's clear from the latest estimates that GVS' rate of growth is expected to accelerate meaningfully, with the forecast 6.5% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 5.0% p.a. over the past five years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 6.4% per year. GVS is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their revenue estimates for next year, suggesting that the business is performing in line with expectations. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at €5.98, with the latest estimates not enough to have an impact on their price targets.

At least one of GVS' four analysts has provided estimates out to 2027, which can be seen for free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with GVS (at least 1 which shouldn't be ignored) , and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.